The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Baclofen 5mg/5ml oral solution

5 mg/5ml Oral solution

Syri Pharma Limited t/a Thame LaboratoriesPA22697/005/001

Main Information

Trade NameBaclofen 5mg/5ml oral solution
Active SubstancesBaclofen
Strength5 mg/5ml
Dosage FormOral solution
Licence HolderSyri Pharma Limited t/a Thame Laboratories
Licence NumberPA22697/005/001

Group Information

ATC CodeM03BX Other centrally acting agents
M03BX01 baclofen

Status

Authorised/WithdrawnAuthorised
Licence Issued12/02/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back